Salarius Pharmaceuticals logo

Salarius Pharmaceuticals Share Price Today

(NASDAQ: SLRX)

Salarius Pharmaceuticals share price is $0.97 & ₹84.32 as on 15 Mar 2025, 2.30 'hrs' IST

$0.97

0.01

(1.31%)

Market is closed - opens 7 PM, 17 Mar 2025

View live Salarius Pharmaceuticals share price in Dollar and Rupees. Guide to invest in Salarius Pharmaceuticals stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Salarius Pharmaceuticals, along with analyst recommendations, forecasts, and comprehensive financials.

Salarius Pharmaceuticals share price movements

  • Today's Low: $0.95
    Today's High: $1.00

    Day's Volatility :5.19%

  • 52 Weeks Low: $0.90
    52 Weeks High: $7.20

    52 Weeks Volatility :87.5%

Salarius Pharmaceuticals (SLRX) Returns

PeriodSalarius Pharmaceuticals Inc.Index (Russel 2000)
3 Months
-30.03%
0.0%
6 Months
-40.85%
0.0%
1 Year
-79.93%
0.0%
3 Years
-98.76%
-10.2%

Salarius Pharmaceuticals (SLRX) Key Statistics

in dollars & INR

Previous Close
$0.9575
Open
$0.99
Today's High
$1.002
Today's Low
$0.95
Market Capitalization
$1.5M
Today's Volume
$23.3K
52 Week High
$7.2
52 Week Low
$0.9
Revenue TTM
$0.0
EBITDA
$-5.2M
Earnings Per Share (EPS)
$-5.14
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-110.87%

How to invest in Salarius Pharmaceuticals Stock (SLRX) from India?

It is very easy for Indian residents to invest directly in Salarius Pharmaceuticals from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Salarius Pharmaceuticals stock in both Indian Rupees (INR) and US Dollars (USD). Search for Salarius Pharmaceuticals or SLRX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Salarius Pharmaceuticals or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Salarius Pharmaceuticals shares which would translate to 0.896 fractional shares of Salarius Pharmaceuticals as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Salarius Pharmaceuticals, in just a few clicks!

Returns in Salarius Pharmaceuticals (SLRX) for Indian investors in Rupees

The Salarius Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Salarius Pharmaceuticals investment value today

Current value as on today

₹25,013

Returns

₹74,987

(-74.99%)

Returns from Salarius Pharmaceuticals Stock

₹79,917 (-79.92%)

Dollar Returns

₹4,930 (+4.93%)

Indian investors sentiment towards Salarius Pharmaceuticals (SLRX)

-60%

Period: Feb 13, 2025 to Mar 15, 2025. Change in 30 Days versus previous period

Search interest for Salarius Pharmaceuticals Stock from India on INDmoney has decreased by -60% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Salarius Pharmaceuticals

  • UBS Group AG

    0.45%

  • Advisor Group Holdings, Inc.

    0.01%

Analyst Recommendation on Salarius Pharmaceuticals

Sell

    0%Buy

    50%Hold

    50%Sell

Based on 6 Wall street analysts offering stock ratings for Salarius Pharmaceuticals(by analysts ranked 0 to 5 stars)

Based on 6 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
0
0
0
Hold
3
3
3
Sell
3
3
3

Analyst Forecast on Salarius Pharmaceuticals Stock (SLRX)

What analysts predicted

Upside of 2580.41%

Target:

$26.00

Current:

$0.97

Insights on Salarius Pharmaceuticals Stock (Ticker Symbol: SLRX)

  • Price Movement

    In the last 1 month, SLRX stock has moved down by -40.1%
  • SLRX vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.0% return, outperforming this stock by 143.3%
  • SLRX vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 58.1% return, outperforming this stock by 156.7%

Salarius Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Salarius Pharmaceuticals is currently in a neutral trading position according to technical analysis indicators.

Salarius Pharmaceuticals (SLRX) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Salarius Pharmaceuticals Inc. logo
-40.12%
-40.85%
-79.93%
-98.76%
-99.31%
Regeneron Pharmaceuticals, Inc. logo
-1.1%
-42.17%
-30.53%
-2.68%
35.63%
Beone Medicines Ltd logo
14.95%
31.94%
53.82%
37.11%
63.22%
Vertex Pharmaceuticals Incorporated logo
9.12%
3.13%
22.7%
101.91%
139.86%
Alnylam Pharmaceuticals, Inc. logo
-8.73%
-10.58%
64.01%
48.25%
134.72%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Salarius Pharmaceuticals Inc. logo
NA
NA
0.0
0.0
-1.11
-0.53
NA
2.03
Regeneron Pharmaceuticals, Inc. logo
17.76
17.76
1.01
42.83
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.45
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.4
18.06
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.52
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Salarius Pharmaceuticals Inc. logo
Sell
$1.5M
-99.31%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$74.4B
35.63%
17.76
31.07%
Beone Medicines Ltd logo
NA
$28.6B
63.22%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$129.1B
139.86%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.3B
134.72%
NA
-12.37%

About Salarius Pharmaceuticals

Salarius Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on developing treatments for cancers with unmet medical need. Its lead candidate is Seclidemstat (SP-2577), a small molecular inhibitor which is in Phase I/II clinical trial for the treatment of advanced solid tumors, as well as Ewing sarcoma. The company also offers SP-3164, a small molecular protein degrader for the treatment of hematological and solid tumors. It has a strategic partnership with The University of Utah Research Foundation for the exclusive license with respect to patent rights protecting SP-2577 and related compounds and Cancer Prevention and Research Institute of Texas for product development activities. The company is headquartered in Houston, Texas.
Organization
Salarius Pharmaceuticals
Employees
2
CEO
Mr. David J. Arthur M.B.A.
Industry
Health Technology

Management People of Salarius Pharmaceuticals

NameTitle
Mr. David J. Arthur M.B.A.
CEO, President & Director
Mr. Mark J. Rosenblum CPA
Executive VP of Finance & CFO

Important FAQs about investing in SLRX Stock from India :

What is Salarius Pharmaceuticals share price today?

Salarius Pharmaceuticals share price today stands at $0.97, Open: $0.99 ; Previous Close: $0.96 ; High: $1.00 ; Low: $0.95 ; 52 Week High: $7.20 ; 52 Week Low: $0.90.

The stock opens at $0.99, after a previous close of $0.96. The stock reached a daily high of $1.00 and a low of $0.95, with a 52-week high of $7.20 and a 52-week low of $0.90.

Can Indians buy Salarius Pharmaceuticals shares?

Yes, Indians can invest in the Salarius Pharmaceuticals (SLRX) from India.

With INDmoney, you can buy Salarius Pharmaceuticals at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Salarius Pharmaceuticals at zero transaction cost.

How can I buy Salarius Pharmaceuticals shares from India?

It is very easy to buy Salarius Pharmaceuticals from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Salarius Pharmaceuticals (SLRX) be purchased?

Yes, you can buy fractional shares of Salarius Pharmaceuticals with INDmoney app.

What are the documents required to start investing in Salarius Pharmaceuticals stocks?

To start investing in Salarius Pharmaceuticals, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Salarius Pharmaceuticals Stock (SLRX)?

Today’s highest price of Salarius Pharmaceuticals (SLRX) is $1.00.

Today’s lowest price of Salarius Pharmaceuticals (SLRX) is $0.95.

What is today's market capitalisation of Salarius Pharmaceuticals?

Today's market capitalisation of Salarius Pharmaceuticals SLRX is 1.5M

What is the 52 Week High and Low Range of Salarius Pharmaceuticals Stock (SLRX)?

  • 52 Week High

    $7.20

  • 52 Week Low

    $0.90

What are the historical returns of Salarius Pharmaceuticals (SLRX)?

  • 1 Month Returns

    -40.12%

  • 3 Months Returns

    -40.85%

  • 1 Year Returns

    -79.93%

  • 5 Years Returns

    -99.31%

Who is the Chief Executive Officer (CEO) of Salarius Pharmaceuticals ?

Mr. David J. Arthur M.B.A. is the current Chief Executive Officer (CEO) of Salarius Pharmaceuticals.